Changes in Bronchiolitis Characteristics During the COVID-19 Pandemic: A Description of Pediatric Emergency Department Visits in a Community Hospital, 2019-2021
- PMID: 37872735
- PMCID: PMC11061886
- DOI: 10.1177/00099228231208941
Changes in Bronchiolitis Characteristics During the COVID-19 Pandemic: A Description of Pediatric Emergency Department Visits in a Community Hospital, 2019-2021
Abstract
A retrospective, cross-sectional study of children with bronchiolitis aged 1 to 24 months during an ED visit between 2019 and 2021 was performed. Chi-square or Kruskal-Wallis was used to compare groups. The gamma coefficient was used to measure the association of variables through time. Bronchiolitis cases decreased by 75% from 2019 to 2020 and rose back to prepandemic levels by 2021. Radiographs (gamma -0.443), steroids (gamma -0.298), and bronchodilators (gamma -0.414) decreased during the study period (P < .001). Laboratory studies (gamma 0.032), viral testing (gamma 0.097), antibiotic use (gamma -0.069), and respiratory support (gamma 0.166) were unchanged. The decrease in steroids and bronchodilators was related to a clinical pathway that discouraged their use. Respiratory support remained unchanged. The COVID-19 pandemic (2019-2021) seems to have had little effect on the severity or resource utilization associated with bronchiolitis but may have unraveled a potential bronchiolitis phenotype that may have been more prominent during the pandemic.
Keywords: COVID-19; bronchiolitis; pandemic; pediatric emergency department.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Practice variation among pediatric emergency departments in the treatment of bronchiolitis.Acad Emerg Med. 2004 Apr;11(4):353-60. doi: 10.1197/j.aem.2003.12.003. Acad Emerg Med. 2004. PMID: 15064208
-
Impact of the COVID-19 Pandemic on Low-Value Testing and Treatment of Bronchiolitis.Hosp Pediatr. 2024 Jul 1;14(7):e299-e303. doi: 10.1542/hpeds.2024-007751. Hosp Pediatr. 2024. PMID: 38872617
-
Comparison Between Physicians' and Nurse Practitioners' Resource Utilization in the Diagnosis and Management of Bronchiolitis in the Pediatric Emergency Department.Pediatr Emerg Care. 2022 Sep 1;38(9):e1564-e1568. doi: 10.1097/PEC.0000000000002608. Epub 2021 Dec 23. Pediatr Emerg Care. 2022. PMID: 36040473 Free PMC article.
-
Acute bronchiolitis: assessment and management in the emergency department.Pediatr Emerg Med Pract. 2019 Oct;16(10):1-24. Epub 2019 Oct 2. Pediatr Emerg Med Pract. 2019. PMID: 31557431 Review.
-
[Treatment of acute bronchiolitis in infants. Role of bronchodilators and steroids].Arch Pediatr. 1996 Apr;3(4):383-9. doi: 10.1016/0929-693x(96)84696-3. Arch Pediatr. 1996. PMID: 8762963 Review. French.
References
-
- US Dept of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA. 2017–2018 Estimated Flu Illnesses, Medical Visits, Hospitalizations, and Deaths and Estimated Flu-Related Prevented by Vaccination in the United States. https://www.cdc.gov/flu/about/burden-averted/2017-2018.htm#table1. Accessed July 17, 2023.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
